Indoco's Baddi facility receives EUGMP certification from Health Authority of Germany
The EU certification will support supplies of drug products registered in Europe, from this manufacturing site
The EU certification will support supplies of drug products registered in Europe, from this manufacturing site
The approval paves the way for consolidating the company’s position in Kenya and other African markets as part of its global expansion plans
This approval reflects Biocon Biologics' compliance with the highest international regulatory standards
The company has received the Certificate of GMP Compliance from the representative European inspection authority, Health Products Regulatory Authority (HPRA), Ireland.
This integrated, multi-product facility houses manufacturing suites, analytical testing laboratories and warehousing.
The expansion makes Exothera one of the largest viral vector facilities in Europe
The facility will manufacture its Herceptin biosimilar, Tuznue
The GMP certificate is valid for three years until April 2024.
Marksans Pharma gets USFDA nod for acid reflux drug
Subscribe To Our Newsletter & Stay Updated